Aton Ra Partners Guardant Health, Inc. Transaction History
Aton Ra Partners
- $50.1 Million
- Q4 2023
A detailed history of Aton Ra Partners transactions in Guardant Health, Inc. stock. As of the latest transaction made, Aton Ra Partners holds 9,348 shares of GH stock, worth $220,612. This represents 0.5% of its overall portfolio holdings.
Number of Shares
9,348
Previous 9,756
4.18%
Holding current value
$220,612
Previous $289,000
12.8%
% of portfolio
0.5%
Previous 0.61%
Shares
13 transactions
Others Institutions Holding GH
# of Institutions
331Shares Held
113MCall Options Held
680KPut Options Held
1.67M-
Vanguard Group Inc Valley Forge, PA11.6MShares$275 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$265 Million0.01% of portfolio
-
Baillie Gifford & CO6.09MShares$144 Million0.14% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.5MShares$106 Million4.27% of portfolio
-
Capital International Investors Los Angeles, CA4.47MShares$105 Million0.03% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $2.41B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...